Literature DB >> 8376812

Secular trends in hepatitis A virus infection among Alaska Natives.

L R Bulkow1, R B Wainwright, B J McMahon, J P Middaugh, S A Jenkerson, H S Margolis.   

Abstract

To assess the epidemiologic characteristics of the population susceptible to hepatitis A virus (HAV) infection and determine the natural history of infection, a retrospective survey was done using banked serum specimens. A random sample of 4030 Alaska Natives statewide was selected, stratified by year of birth and community of residence. Overall, 1988 serum samples (49.3%) tested positive for antibody to HAV (anti-HAV). Past HAV infection was strongly age-related, increasing from 7% in persons born since 1975 to 85% among persons born before 1945. Prevalence of infection also varied between regions. In small communities, a clear demarcation typically existed between previously infected older persons and younger anti-HAV-negative persons. This indicated that village-wide outbreaks of HAV infection have been the norm and appear to be dependent on the presence of a young susceptible population. Widespread vaccination with hepatitis A vaccine to maintain a high proportion of young anti-HAV-positive persons may be successful in preventing future epidemics.

Entities:  

Mesh:

Year:  1993        PMID: 8376812     DOI: 10.1093/infdis/168.4.1017

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Diagnosis of hepatitis a virus infection: a molecular approach.

Authors:  Omana V Nainan; Guoliang Xia; Gilberto Vaughan; Harold S Margolis
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China.

Authors:  Zhi-lun Zhang; Xiang-jun Zhu; Ai-lan Shan; Zhi-gang Gao; Ying Zhang; Ya-xing Ding; Hui Liu; Wei-shen Wu; Yong Liu; Hai-yan He; Xiao-hua Xie; Wei-dong Xia; Chao Li; Wen-ti Xu; Zhi-yuan Li; Hua-liang Lin; Wei-ming Fu
Journal:  Hum Vaccin Immunother       Date:  2014-02-06       Impact factor: 3.452

3.  Changing trends in viral hepatitis-associated hospitalizations in the American Indian/Alaska Native population, 1995-2007.

Authors:  Kathy K Byrd; John T Redd; Robert C Holman; Dana L Haberling; James E Cheek
Journal:  Public Health Rep       Date:  2011 Nov-Dec       Impact factor: 2.792

4.  Hepatitis A among schoolchildren in a US-Mexico border community.

Authors:  T Redlinger; K O'Rourke; J VanDerslice
Journal:  Am J Public Health       Date:  1997-10       Impact factor: 9.308

Review 5.  New developments in hepatitis A control.

Authors:  L Yuan
Journal:  Can Fam Physician       Date:  1995-07       Impact factor: 3.275

6.  Hepatitis A incidence and hepatitis a vaccination among American Indians and Alaska Natives, 1990-2001.

Authors:  Stephanie R Bialek; Douglas A Thoroughman; Diana Hu; Edgar P Simard; Jody Chattin; Jim Cheek; Beth P Bell
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

Review 7.  Chronic liver disease in Aboriginal North Americans.

Authors:  John D Scott; Naomi Garland
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

8.  Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children.

Authors:  Gregory A Raczniak; Timothy K Thomas; Lisa R Bulkow; Susan E Negus; Carolyn L Zanis; Michael G Bruce; Philip R Spradling; Eyasu H Teshale; Brian J McMahon
Journal:  Vaccine       Date:  2013-03-05       Impact factor: 3.641

9.  Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series.

Authors:  Gregory A Raczniak; Lisa R Bulkow; Michael G Bruce; Carolyn L Zanis; Richard L Baum; Mary M Snowball; Kathy K Byrd; Umid M Sharapov; Thomas W Hennessy; Brian J McMahon
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.